Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study):
multicentre randomised placebo-controlled trial

Lancet. 2003 Nov 8;362(9395):1517-26.
Zajicek J, Fox P, Sanders H, Wright D, Vickery J, Nunn A, Thompson A; UK MS Research Group.
Peninsula Medical School, Plymouth, UK. john.zajicek@phnt.swest.nhs.uk

Read the paper

Lancet Commentrary: Oral cannabinoids for spasticity in multiple sclerosis: will attitude continue to limit use?